In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Ahn-Gook Pharmaceutical has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
KOSDAQ:A001540 - Analysts future estimates and past financials data (KRW Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2026
330,050
16,268
41,460
50,794
N/A
12/31/2025
306,874
7,481
37,087
45,683
N/A
9/30/2025
300,958
9,879
37,222
43,275
N/A
6/30/2025
290,775
6,103
29,701
37,997
N/A
3/31/2025
281,128
12,632
8,498
20,714
N/A
12/31/2024
271,116
16,845
-71,368
4,914
N/A
9/30/2024
264,636
14,281
-69,955
7,359
N/A
6/30/2024
252,480
15,349
-84,230
-10,239
N/A
3/31/2024
244,223
6,406
-85,562
-16,249
N/A
12/31/2023
233,676
1,290
-7,511
-1,328
N/A
9/30/2023
226,186
4,581
-10,356
-4,583
N/A
6/30/2023
224,219
7,801
3,792
9,035
N/A
3/31/2023
213,414
8,298
2,905
7,430
N/A
12/31/2022
205,389
6,875
-1,878
1,788
N/A
9/30/2022
195,740
9,471
2,331
5,745
N/A
6/30/2022
182,760
7,005
-692
3,063
N/A
3/31/2022
175,163
4,077
-1,874
3,319
N/A
12/31/2021
163,534
3,939
-3,591
1,472
N/A
9/30/2021
149,137
1,391
-26,212
-698
N/A
6/30/2021
143,734
242
-29,439
-3,761
N/A
3/31/2021
141,126
-2,505
-20,892
3,766
N/A
12/31/2020
143,364
-1,315
-13,284
11,190
N/A
9/30/2020
156,318
-1,003
6,184
10,332
N/A
6/30/2020
160,059
215
21,598
24,970
N/A
3/31/2020
158,870
3,339
14,306
17,727
N/A
12/31/2019
155,852
2,536
N/A
22,078
N/A
9/30/2019
167,392
7,416
N/A
21,312
N/A
6/30/2019
173,064
8,524
N/A
1,395
N/A
3/31/2019
179,166
12,862
N/A
1,748
N/A
12/31/2018
185,746
13,220
N/A
-1,201
N/A
9/30/2018
177,663
7,111
N/A
11,493
N/A
6/30/2018
177,601
8,641
N/A
17,725
N/A
3/31/2018
179,556
8,209
N/A
16,010
N/A
12/31/2017
183,600
8,159
N/A
17,464
N/A
9/30/2017
182,032
9,839
N/A
3,862
N/A
6/30/2017
179,048
5,884
N/A
9,188
N/A
3/31/2017
176,178
2,700
N/A
13,122
N/A
12/31/2016
174,002
1,715
N/A
12,622
N/A
9/30/2016
183,923
-185
N/A
21,903
N/A
6/30/2016
188,194
3,025
N/A
20,365
N/A
3/31/2016
195,871
7,926
N/A
26,472
N/A
12/31/2015
197,736
9,364
N/A
19,106
N/A
9/30/2015
185,569
4,360
N/A
10,633
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A001540's forecast earnings growth is above the savings rate (3.1%).
Earnings vs Market: Insufficient data to determine if A001540's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A001540's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A001540's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A001540's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A001540's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/08 19:26
End of Day Share Price
2026/07/08 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ahn-Gook Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.